Karan Abhinav, Kiamos Amy, Reddy Pramod
Internal Medicine, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.
Cureus. 2023 Feb 25;15(2):e35469. doi: 10.7759/cureus.35469. eCollection 2023 Feb.
Thrombotic storm is a rare hypercoagulable condition characterized by a clinical trigger causing extensive thrombotic events affecting multiple vessels over a short period of time. We present a case of thrombotic storm that developed in a patient who received rituximab therapy. The patient presented to the hospital with dyspnea and shortness of breath and was subsequently diagnosed with extensive thrombotic burden including multiple deep vein thrombi and pulmonary emboli. Hypercoagulable workup for the thrombotic storm was unrevealing with the only identifiable trigger being the rituximab infusion. The patient was treated successfully with anticoagulation and discontinuation of rituximab. There are very few reports highlighting thrombotic events as a complication of rituximab therapy. We aim to increase recognition of thrombotic storm as a potential complication of receiving rituximab therapy.
血栓风暴是一种罕见的高凝状态,其特征是由临床触发因素导致在短时间内发生广泛的血栓形成事件,影响多个血管。我们报告一例接受利妥昔单抗治疗的患者发生血栓风暴的病例。该患者因呼吸困难和气促入院,随后被诊断为存在广泛的血栓负荷,包括多个深静脉血栓和肺栓塞。对该血栓风暴进行的高凝检查未发现异常,唯一可识别的触发因素是利妥昔单抗输注。患者通过抗凝治疗和停用利妥昔单抗获得成功治疗。很少有报告强调血栓形成事件是利妥昔单抗治疗的并发症。我们旨在提高对血栓风暴作为接受利妥昔单抗治疗潜在并发症的认识。